Alcon launches new phaco system

Fort Worth, TX-Alcon Laboratories has announced the global launch of its new phacoemulsification technology platform, a vision system designed to provide surgeons with enhanced cataract removal capabilities.

The new Centurion Vision System automatically and continuously adapts to changing conditions within the eye, providing anterior chamber stability during each step of surgery. The technology also increases efficiency and control-while reducing energy levels-and accommodating surgeon settings for aspiration and vacuum by keeping the fragmented lens material at the shearing plane for emulsification.

The vision system includes an improved ergonomic design with a wireless footswitch and intuitive touch-screen display as well.

To date, more than 40 surgeons around the world have tested the new vision system for more than 2,000 cataract surgeries.

“As the world leader in eye care, Alcon is on the frontlines of delivering new innovations to help improve cataract care,” said Stephen Speares, global head of cataract franchise, Alcon. “By combining multiple proprietary technologies and unique innovations as part of the  . . . vision system, we are offering surgeons the next-generation phaco platform that will enable them to optimize every step of the cataract surgery, and ultimately help deliver exceptional patient outcomes.”

The vision system will be available in 2013 to those countries where the new phaco system has received the necessary regulatory approvals. Alcon will continue its global rollout through 2014.

Live surgery demonstrations of the vision system will take place during the upcoming meetings of European Society of Cataract and Refractive Surgerons, and American Academy of Ophthalmology.

For more about the vision system, visit www.centurionvisionsystem.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.